Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NCT07226843 · PHASE1 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular

PR
By Priya Raman · Science Reporter
Nov 4 07:00 ETSource: ClinicalTrials.gov

From the source

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NCT07226843 · PHASE1 · RECRUITING · Sponsor: Eli Lilly and Company · Conditions: Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →